K. Wagner, A. Nunes, F.J. Fernandes, M. Poti de Morais, M. de Almeida, L.M.A. Ramos
Cutaneous leishmaniasis in a patient with ankylosing spondylitis...
S. Habibi-Naderizadeh, C. Valcárcel-Sierra, L. Medrano-Gallego, B.J. Flores-Robles, L.G. Roustán-Gullón
Leishmaniasis mucocutánea en pacientes...
P. Zanger, I. Kötter, P.G. Kremsner, S. Gabrysch
Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe
Clin Microbiol Infect.,...
P. Zanger, S. Gabrysch
Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy – a research agenda for Europe
Euro Surveill.,...
A. Català, E. Roé, J. Dalmau, V. Pomar, C. Muñoz, O. Yelamos, et al.
Anti-tumour necrosis factor-induced visceral and cutaneous Leishmaniasis:...
C. Guarneri, V. Bevelacqua, J. Patterson, G. Tchernev
Cutaneous and visceral leishmaniasis during anti-TNFα therapy
Wien Med Wochenschr.,...
J. Van Griensven, E. Carrillo, R. Lopez-Velez, L. Lynen, J. Moreno
Leishmaniasis in immunosuppressed individuals
Clin Microbiol Infect., 20...
N. Aronson, B.L. Herwaldt, M. Libman, R. Pearson, R. Lopez-Velez, P. Weina, et al.
Diagnosis and Treatment of Leishmaniasis: Clinical Practice...
Leishmaniasis. Resources for Health Professionals. [consultado 15 Oct 2018]. Disponible en https://www.cdc.gov/parasites/leishmaniasis/health_professionals/index.html#.
P. Giavedoni, P. Iranzo, I. Fuertes, T. Estrach, M. Alsina-Gibert
Cutaneous leismaniasis: 20 years’ experience in a Spanish tertiary care...